Bluefish Pharmaceuticals AB (Bluefish Pharmaceuticals) develops, manufactures, and markets generic pharmaceuticals. The company offers products for various therapeutic areas including cardiovascular, the central nervous system, gastrointestinal, diabetes, oncology, dermatology, respiratory, inflammatory, genito-urinary, antifungal, antiviral, endocrinology, analgesic and antibiotics. Some of its products are under clinical evaluation. Bluefish develops products concentrating on product selection, geographic access, costs, supply chain operations and intellectual property rights. It products are used in the treatment of diabetes, breast cancer, depression and anxiety disorders, seizures, migraine headaches, panic attacks, schizophrenia and schizophrenia, among others. The company has operations in various countries in Europe through its subsidiaries. Bluefish Pharmaceuticals is headquartered in Stockholm, Sweden.
Bluefish Pharmaceuticals AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents 2
List of Tables 3
List of Figures 4
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Bluefish Pharma Enters Into Licensing Agreement For Two Products 10
Bluefish Pharma Enters Into Licensing Agreement For Fifteen Products 10
Equity Offering 11
Bluefish Pharma Completes Private Placement Of Shares For US$6.2 Million 11
Bluefish Pharma Completes Private Placement Of Shares For US$11.8 Million 12
Bluefish Pharma Completes Private Placement Of Shares For US$2.8 Million 13
Bluefish Pharma Completes Private Placement Of Shares For US$6 Million 14
Debt Offering 15
Bluefish Pharma Completes Convertible Bond Issue For US$6.1 Million 15
Acquisition 16
Bluefish Pharma Acquires BMM Pharma From BioPhausia 16
Bluefish Pharmaceuticals AB - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.